Home Cart Sign in  
Chemical Structure| 60628-96-8 Chemical Structure| 60628-96-8

Structure of Bifonazole
CAS No.: 60628-96-8

Chemical Structure| 60628-96-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bifonazole is a substituted imidazole antifungal agent, working by inhibiting the production of ergosterol, which is an essential component of fungal cell membranes.

Synonyms: Bay H-4502; (±)-Bifonazole; Moldina

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bifonazole

CAS No. :60628-96-8
Formula : C22H18N2
M.W : 310.39
SMILES Code : N1(C(C2=CC=C(C3=CC=CC=C3)C=C2)C4=CC=CC=C4)C=CN=C1
Synonyms :
Bay H-4502; (±)-Bifonazole; Moldina
MDL No. :MFCD00865567
InChI Key :OCAPBUJLXMYKEJ-UHFFFAOYSA-N
Pubchem ID :2378

Safety of Bifonazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
VeroE6 cells 30-40 μM 15 min To evaluate the inhibitory effect of Bifonazole on VSV-Spike-GFP infection. Results showed that Bifonazole significantly reduced the number of infected cells with an IC50 of 30-40 μM. Mol Ther. 2022 Sep 7;30(9):2998-3016
HEK293 cells 4 μM 1 hour To evaluate the inhibitory effect of Bifonazole on the binding of SARS-CoV-2 RBD to ACE2. Results showed that Bifonazole significantly inhibited RBD-ACE2 binding with an inhibition rate of approximately 50%. Mol Ther. 2022 Sep 7;30(9):2998-3016
vaginal epithelial cells A-431 1 μM and 10 μM 1, 3, or 24 h To investigate the effects of Bifonazole on C. albicans adhesion, invasion, and damage to vaginal epithelial cells. Results showed that Bifonazole treatment significantly reduced epithelial damage but did not affect adhesion or invasion. Antimicrob Agents Chemother. 2011 Sep;55(9):4436-9
Rhodotorula mucilaginosa 10 mg/mL Evaluate the effects on fungal growth and carotenoid synthesis, results showed Bifonazole did not affect carotenoid synthesis Jörg.) F.C. Harrison causing onychomycosis.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
CB17-SCID mice ESCC patient-derived xenograft (PDX) model Oral gavage 50 mg/kg, 100 mg/kg Once daily for 24 or 36 days To evaluate the antitumor effects of Bifonazole in vivo. Results showed that Bifonazole significantly inhibited tumor growth and decreased RRM2 protein levels and the dNTP pool. Acta Pharm Sin B. 2024 Oct;14(10):4329-4344
K18-hACE2 transgenic mice VSV-Spike infection model Intranasal administration 125 μM Daily administration for 6 days To evaluate the protective effect of Bifonazole in VSV-Spike-infected mice. Results showed that the survival rate in the Bifonazole-treated group was 40%, significantly higher than the control group. Mol Ther. 2022 Sep 7;30(9):2998-3016

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.22mL

0.64mL

0.32mL

16.11mL

3.22mL

1.61mL

32.22mL

6.44mL

3.22mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories